SEC Filing Summary: Global Medical REIT Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Global Medical REIT Inc. on September 14, 2017, reporting events occurring on September 12, 2017. The Company is an emerging growth company incorporated in Maryland. The filing details the entry into a material definitive agreement for a public offering of preferred stock.
Key Financial Metrics and Transaction Details
- Security Issued: 7.50% Series A Cumulative Redeemable Preferred Stock.
- Shares Sold: 2,700,000 shares initially, plus 405,000 shares pursuant to the full exercise of the over-allotment option, totaling 3,105,000 shares.
- Offering Price: $25.00 per share.
- Estimated Net Proceeds: Approximately $75 million (after underwriting discounts, commissions, and estimated offering expenses).
- Use of Proceeds: Funding new acquisitions and repaying indebtedness.
- Underwriter: FBR Capital Markets & Co. (as representative).
Material Changes and Corporate Actions
The Company entered into an Underwriting Agreement on September 12, 2017. On September 14, 2017, the underwriters exercised their over-allotment option in full. Consequently, the Company filed Articles Supplementary with the Maryland State Department of Assessments and Taxation to designate 3,105,000 shares of preferred stock as the 7.50% Series A Cumulative Redeemable Preferred Stock. The Company intends to contribute the net proceeds to its Operating Partnership in exchange for preferred units.
Guidance, Risks, and Contingencies
Restrictions on Distributions: The issuance of the Series A Preferred Stock imposes restrictions on the Company's ability to make distributions, redeem, purchase, or acquire, or make liquidation payments on any other shares of capital stock ranking junior to or on a parity with the Series A Preferred Stock. These restrictions apply if the Company fails to declare distributions on the Series A Preferred Stock during any distribution period.
Underwriter Relationships: The underwriters have engaged in, and may continue to engage in, investment banking and other commercial dealings with the Company or its affiliates in the ordinary course of business.
Investor Verification Checklist
- Verify the final net proceeds received after all offering expenses are settled.
- Review the Articles Supplementary (Exhibit 3.1) for specific terms regarding redemption and dividend priority.
- Confirm the specific allocation of proceeds between new acquisitions and debt repayment.
- Examine the First Amendment to the Agreement of Limited Partnership (Exhibit 10.1) for details on the preferred units issued to the Operating Partnership.